CGON
CG Oncology, Inc. Common stock
NASDAQ · Healthcare · Biotechnology · US
$74.67
+0.46%Margins
Gross margin
-82.7%
EBITDA margin
-3568.9%
EBIT margin
-4056.2%
Net margin
-3602.7%
FCF margin
-2879.6%
-21.8%
Return on equity
-20.7%
Return on assets
-24.3%
Return on invested capital
0.01x
Asset turnover
-$178.5M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026